Autoantibodies as the Early Diagnostic Biomarkers for Lung Cancer
Autoantibodies as the Early Diagnostic Biomarkers for Lung Cancer
About this item
Full title
Author / Creator
Publisher
Tianjin: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
Tianjin: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
肺癌是当今世界上对人类健康与生命危害最大的恶性肿瘤之一，其死亡率居各类恶性肿瘤所致死亡的首位。世界卫生组织（World Health Organization, WHO）预测，到2025年中国每年将有超过一百万新发肺癌患者[1]。最新统计数据[2,3]显示，肺癌的总5年生存率仅10%-16%，而I期患者的5年生存率可达65%-75%。虽然目前临床上已经联合影像学技术、痰细胞学检测、纤维支气管镜等多种检测手段，但对无症状早期肺癌的诊断效果甚微，多数患者在就诊时已发展至晚期。因此，寻找有效的早期诊断技术和方法对于延长患者生命至关重要。 近年来，许多研究[4-9]表明肿瘤在发生早期即可激发宿主体内产生体液免疫，在多种肿瘤包括肺癌患者的血清中，均可检测到针对肿瘤相关抗原（tumour-associa...
Alternative Titles
Full title
Autoantibodies as the Early Diagnostic Biomarkers for Lung Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b2346ca747ab429587dcc285f15b16d8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b2346ca747ab429587dcc285f15b16d8
Other Identifiers
ISSN
1009-3419
E-ISSN
1999-6187
DOI
10.3779/cjlc.v13i9.1407
